Article Versions Notes

Abdoli M, Angeli A, Bonardi A, Gratteri P, Jackevica L, Sizovs A, Supuran CT, Žalubovskis R. Investigation on N-Aryl-2-(4-sulfamoylphenyl)hydrazine-1-carbothioamide as Human Carbonic Anhydrases Inhibitors. Pharmaceuticals. 2026; 19(1):151. https://doi.org/10.3390/ph19010151

Abdoli, Morteza, Andrea Angeli, Alessandro Bonardi, Paola Gratteri, Ludmila Jackevica, Antons Sizovs, Claudiu T. Supuran, and Raivis Žalubovskis. 2026. "Investigation on N-Aryl-2-(4-sulfamoylphenyl)hydrazine-1-carbothioamide as Human Carbonic Anhydrases Inhibitors" Pharmaceuticals 19, no. 1: 151. https://doi.org/10.3390/ph19010151

Abdoli, M., Angeli, A., Bonardi, A., Gratteri, P., Jackevica, L., Sizovs, A., Supuran, C. T., & Žalubovskis, R. (2026). Investigation on N-Aryl-2-(4-sulfamoylphenyl)hydrazine-1-carbothioamide as Human Carbonic Anhydrases Inhibitors. Pharmaceuticals, 19(1), 151. https://doi.org/10.3390/ph19010151